Cas:59142-68-6 2-Bromo-4-fluorobenzaldehyde manufacturer & supplier

We serve Chemical Name:2-Bromo-4-fluorobenzaldehyde CAS:59142-68-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Bromo-4-fluorobenzaldehyde

Chemical Name:2-Bromo-4-fluorobenzaldehyde
CAS.NO:59142-68-6
Synonyms:2-Brom-4-fluorbenzolcarbaldehyd;2-Brom-4-fluorbenzaldehyd;MFCD00672923;2-Bromo-4-Fluoro Benzaldehyde;2-bromo-4-fluoroaldehyde;4-fluoro-2-bromo-benzaldehyde;2-Bromo-4-fluorobenzaldehyde;Benzaldehyde, 2-bromo-4-fluoro-;2-bromo-4-fluoro-benzaldehyde
Molecular Formula:C7H4BrFO
Molecular Weight:203.008
HS Code:2912299000

Physical and Chemical Properties:
Melting point:61.5ºC
Boiling point:234.9±20.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.585
PSA:17.07000
Exact Mass:201.942947
LogP:2.31

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Brom-4-fluorbenzolcarbaldehyd chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-4-fluoro-benzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzaldehyde, 2-bromo-4-fluoro- Use and application,2-Brom-4-fluorbenzaldehyd technical grade,usp/ep/jp grade.


Related News: The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients. 5-dimethoxymethyl-6-methyl-2-thioxo-tetrahydro-pyrimidin-4-one manufacturers Flexibility in a CDMO is the key to ensure speed of tech-transfer which is a true litmus test for CDMOs which can help a company chose between competing analytical strategies, manufacturing technology and knowledge for improving productivity. 1-(4-dimethylamino-phenyl)-3-(4-methyl-piperazin-1-yl)-propenone suppliers Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. rel-((2R,5S)-2,5-dimethoxy-2,5-dihydrofuran-2-yl)methyl acetate vendor & factory.